GGrantIndex
← Leaderboards

Curtis R Brandt

University Of Wisconsin Madison

Google Scholar ↗PubMed ↗ORCID ↗
$8,345,007
Attributed
$9,324,747
Total exposure
15
Grants
11
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.9M · FY2005–21
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21

Funding mix

By agency

NIH$22,391,037 · 17

By mechanism

P30$10,888,928 · 6
R01$4,607,115 · 3
P01$3,464,298 · 2
R44$1,424,920 · 1
R21$823,338 · 2
S10$528,573 · 1

Top collaborators

Most similar at University Of Wisconsin Madison

Same institution · by research overlap

Others in their field

Top investigators on “Vision Research”

Research focus

Vision ResearchCellsResearch PersonnelVisionEye InfectionsInfectionUniversitiesWisconsinKeratitisBlindnessGrantVirusServicesSimplexvirusGene DeliveryMolecular BiologyAntiviral AgentsVectorAnimal ModelAffectGenesIn VivoRodentViral

Grant awards (61)

UW Vision Research Core$622,000
P30 · FY2021 · EY · contact PI
UW Vision Research Core 4 - Biostatistics and Epidemiology$48,510
P30 · FY2021 · EY · contact PI
UW Vision Research Core - Administrative Core$43,243
P30 · FY2021 · EY · contact PI
Core Grant for Vision Research$612,000
P30 · FY2020 · EY · contact PI
Neurovirulent HSV-1 Recombinants for vQTL Analysis$229,500
R21 · FY2020 · AI · contact PI
Core Grant for Vision Research$37,713
P30 · FY2020 · EY · contact PI
Core Grant for Vision Research$612,000
P30 · FY2019 · EY · contact PI
Enhancing Basic and Translational Vision Research Using Animals$528,573
S10 · FY2019 · OD · contact PI
Neurovirulent HSV-1 Recombinants for vQTL Analysis$191,250
R21 · FY2019 · AI · contact PI
Core Grant for Vision Research$37,713
P30 · FY2019 · EY · contact PI
Biological Treatment of Bacterial Keratitis$721,237
R44 · FY2018 · EY
Core Grant for Vision Research$612,000
P30 · FY2018 · EY · contact PI
Biological Treatment of Bacterial Keratitis$532,480
R44 · FY2018 · EY
Core Grant for Vision Research$37,713
P30 · FY2018 · EY · contact PI
Core Grant for Vision Research$612,000
P30 · FY2017 · EY · contact PI
Biological Treatment of Bacterial Keratitis$171,203
R44 · FY2017 · EY
Core Grant for Vision Research$37,713
P30 · FY2017 · EY · contact PI
Core Grant for Vision Research$612,000
P30 · FY2016 · EY · contact PI
Core Grant for Vision Research$37,713
P30 · FY2016 · EY · contact PI
Core Grant for Vision Research$602,000
P30 · FY2015 · EY · contact PI
Virulence Genes in Herpes Simplex Virus Ocular Infection$456,262
R01 · FY2015 · EY · contact PI
Biological treatment of bacterial keratitis$224,999
R41 · FY2015 · EY
Core Grant for Vision Research$602,000
P30 · FY2014 · EY · contact PI
Virulence Genes in Herpes Simplex Virus Ocular Infection$456,262
R01 · FY2014 · EY · contact PI
Core Grant for Vision Research$602,000
P30 · FY2013 · EY · contact PI
Virulence Genes in Herpes Simplex Virus Ocular Infection$465,574
R01 · FY2013 · EY · contact PI
Pathogenesis of Vaccinia virus keratitis$214,463
R21 · FY2013 · EY · contact PI
Core Grant for Vision Research$602,000
P30 · FY2012 · EY · contact PI
Pathogenesis of Vaccinia virus keratitis$188,125
R21 · FY2012 · EY · contact PI
Core Grant for Vision Research$602,000
P30 · FY2011 · EY · contact PI
Virion Sialic Acid and HSV Ocular Infection$352,836
R01 · FY2011 · EY · contact PI
Virion Sialic Acid and HSV Ocular Infection$367,538
R01 · FY2010 · EY · contact PI
Core Grant for Vision Research$616,898
P30 · FY2009 · EY · contact PI
Virion Sialic Acid and HSV Ocular Infection$371,250
R01 · FY2009 · EY · contact PI
CORE--GENE DELIVERY/QUANTITATIVE MOLECULAR BIOLOGY$211,803
P30 · FY2009 · EY · contact PI
Core Grant for Vision Research$598,938
P30 · FY2008 · EY · contact PI
Virion Sialic Acid and HSV Ocular Infection$371,250
R01 · FY2008 · EY · contact PI
Virus specific factors of HSV to corneal disease$270,098
R01 · FY2008 · EY · contact PI
CORE--GENE DELIVERY/QUANTITATIVE MOLECULAR BIOLOGY$205,638
P30 · FY2008 · EY · contact PI
Core Grant for Vision Research$581,491
P30 · FY2007 · EY · contact PI
Virus specific factors of HSV to corneal disease$275,706
R01 · FY2007 · EY · contact PI
CORE--GENE DELIVERY/QUANTITATIVE MOLECULAR BIOLOGY$199,648
P30 · FY2007 · EY · contact PI
Promoters for Glaucoma Gene Therapy$141,285
R03 · FY2007 · EY · contact PI
Core Grant for Vision Research$564,553
P30 · FY2006 · EY · contact PI
Virus specific factors of HSV to corneal disease$277,329
R01 · FY2006 · EY · contact PI
CORE--GENE DELIVERY/QUANTITATIVE MOLECULAR BIOLOGY$185,064
P30 · FY2006 · EY · contact PI
Promoters for Glaucoma Gene Therapy$142,081
R03 · FY2006 · EY · contact PI
Core Grant for Vision Research$548,112
P30 · FY2005 · EY
Virus specific factors of HSV to corneal disease$284,074
R01 · FY2005 · EY
CORE--GENE DELIVERY/QUANTITATIVE MOLECULAR BIOLOGY$179,676
P30 · FY2005 · EY
Promoters for Glaucoma Gene Therapy$145,500
R03 · FY2005 · EY
ADMINISTRATION$24,789
P30 · FY2005 · EY
Microbicidal peptides to prevent viral STD infection$918,161
P01 · FY2004 · AI
Virus specific factors of HSV to corneal disease$309,142
R01 · FY2004 · EY
Microbicidal peptides to prevent viral STD infection$891,417
P01 · FY2003 · AI
Microbicidal peptides to prevent viral STD infection$782,580
P01 · FY2002 · AI
PEPTIDE INHIBITION OF HSV ENTRY$0
P01 · FY2002 · AI
Microbicidal peptides to prevent viral STD infection$872,140
P01 · FY2001 · AI
VIRUS SPECIFIC FACTORS IN HSV CORNEAL DISEASE$185,406
R01 · FY2001 · EY
PEPTIDE INHIBITION OF HSV ENTRY$0
P01 · FY2001 · AI
VIRUS SPECIFIC FACTORS IN HSV CORNEAL DISEASE$164,388
R01 · FY2000 · EY